XML 51 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Condensed Statements Of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jan. 31, 2020
Jan. 31, 2019
Cash flows from operating activities:    
Net income $ 107,189 $ 107,264
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 121,657 106,281
Stock-based compensation expense 10,789 9,900
Deferred income taxes, net 23,568 32,279
Other non-cash income, net (977) (345)
Changes in assets and liabilities:    
Trade receivables, net 167,417 145,305
Inventories, net (14,237) (14,398)
Accounts payable and accrued liabilities 70,873 97,083
Deferred revenue 72,831 48,061
Income taxes payable - excess tax benefit from share award exercises (2,818) (4,711)
Income taxes payable - other (17,647) (18,000)
Other assets and liabilities, net (956) (2,538)
Net cash provided by operating activities 537,689 506,181
Cash flows from investing activities:    
Capital expenditures (121,788) (113,531)
Acquisition of businesses, net of cash acquired (327,555) (292,610)
Other investing activities, net 3,597 1,817
Net cash used in investing activities (445,746) (404,324)
Cash flows from financing activities:    
Proceeds from borrowings under Vail Holdings Credit Agreement 492,625 335,625
Proceeds from borrowings under Whistler Credit Agreement 0 7,667
Repayments of borrowings under Vail Holdings Credit Agreement (355,625) (211,875)
Repayments of borrowings under Whistler Credit Agreement (18,863) (11,193)
Employee taxes paid for share award exercises (9,966) (11,657)
Dividends paid (142,050) (118,714)
Repurchases of common stock (21,444) (85,000)
Other financing activities, net (14,513) (9,864)
Net cash used in financing activities (69,836) (105,011)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (48) (2,563)
Net increase (decrease) in cash, cash equivalents and restricted cash 22,059 (5,717)
Cash, cash equivalents and restricted cash:    
Beginning of period 118,389 185,040
End of period 140,448 179,323
Accrued capital expenditures $ 11,982 $ 22,731